A component of streptovaricin complex inhibits the replication of poxvirus. To be effective, the inhibitor must be introduced early in the replication cycle; it appears to inhibit early messenger ribonucleic acid synthesis by viral cores, thus interfering with all subsequent events. Neither of the two major components of the complex, streptovaricin A or C, was the active component.
Poxvirus replication is selectively inhibited by rifampin (1, 8, 14) , a semisynthetic derivative of rifamycin. In the presence of rifampin, early and late vaccinia messenger ribonucleic acid (mRNA) synthesis takes place (8, 4) ; progeny ribonucleic acid (RNA) polymerase activity fails to appear (4), perhaps because virus assembly is inhibited (9) , but all viral structural proteins are made (8, 9) . Streptovaricin, a mixture of five structurally similar compounds related to rifamycin (13) , was reported to inhibit bacterial deoxyribonucleic acid (DNA)-dependent RNA polymerase but not the corresponding mammalian enzyme (7) . There are at least three DNA-RNA polymerase activities induced in the cytoplasm of poxvirus-infected cells (5) . Assuming that these activities are essential for virus replication, we thought that it would be interesting to use streptovaricin to selectively inhibit these activities. We find that one poxvirus strain is highly sensitive to streptovaricin and have determined the primary site of inhibition.
MATERIALS AND METHODS
Virus. The Brighton strain of cowpox and the Utrecht strain of rabbitpox were propagated in embryonated eggs. The WR strain of vaccinia virus was grown in HeLa cells. Virus was purified by the method of Planterose et al. (12) .
Cells. HeLa-S8 cells were maintained in suspension in Eagle's medium modified for spinner culture and supplemented with 5% fetal calf serum. Chick embryo fibroblasts (CEF) were grown in medium 199 supplemented with 5% calf serum.
Uridine incorporation into uninfected cells. Confluent monolayers in 60-mm petri dishes were incubated with tritiated uridine (0.5 ,uCi/ml, specific activity 0.6 mCi/mmole) for 60 min. Medium was then removed, and the cells were washed once with 0.1 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride, pH 7.8, containing 5 mg of uridine/ml. An 0.2-ml amount of sodium dodecyl sulfate was added to each plate to lyse the cells. A 1-ml amount of Tris buffer was used to transfer the lysate to tubes, and 1.0 ml of cold 10% trichloroacetic acid was added. The acid-precipitable material was collected on Whatman GF/A glass fiber filters which were subsequently assayed for radioactivity by liquid scintillation spectrometry.
Incorporation of uridine into uninfected HeLa-Ss cells was determined with portions of 5 X 106 cells. These were incubated for 10 min with tritiated uridine (1 ,uCi/ml, specific activity 6 mCi/mmole), and then processed as described above.
Streptovaricin. Unless otherwise noted, streptovaricin refers specifically to streptovaricin complex batch U-7750 provided by the Upjohn Co., Kalamazoo, Mich. Streptovaricins A (batch U 9344) and C (batch U 8741) were also provided by the Upjohn Co. Streptovaricins were dissolved in a few drops of dimethyl sulfoxide and then diluted 50-fold in water to a final concentration of 1 mg/ml. Such solutions were stored in the dark at -10 C.
Determination of viral mRNA and DNA synthesis. Procedures for determination of mRNA and DNA synthesis were as described recently in detail (4) . The rate of viral mRNA synthesis was determined by incorporation of 3H-uridine into the cytoplasm of infected cells.
Assay of induced RNA polymerase, deoxyribonuclease, and core polymerase activity. The assays for induced RNA polymerase, deoxyribonuclease, and core polymerase activity were conducted as described in detail elsewhere (4, 6, 11 Streptovaricin inhibition of one-step growth of poxvirus. The effect of streptovaricin on the onestep replication of cowpox in Hela-S3 cells in suspension is shown in Fig. 3 . The level of streptovaricin necessary to block replication in Hela cells was between 2.5 to 10 ,ug/ml; the inhibitor was without effect if added as late as 5 hr postinfection. Similar results were obtained in experiments on one-step growth of cowpox in CEF at a streptovaricin concentration of 2 pg/ml. Streptovaricins A or C at concentrations of 20 or 10 pug/ml for A and C, respectively, were without effect on cowpox, rabbitpox, or WR strain virus replication in CEF or Hela cells.
Induction of the late enzyme activities RNA polymerase and deoxyribonuclease. From earlier studies with rifampin (9), we expected that streptovaricin might block induction of RNA polymerase activity. Cell cultures were infected with cowpox at an input multiplicity of 10 pockforming units per cell. Streptovaricin (10 the infected cultures were collected for assay of induced RNA polymerase activity or induced acid deoxyribonuclease in the cell cytoplasmic fraction. Results (Fig. 4) showed that growthinhibitory levels of streptovaricin blocked induction of enzyme activities only if added some time before 5 hr postinfection. Streptovaricins A or C at levels of 20 to 10 ,ug/ml, respectively, did not inhibit cowpox polymerase induction even if added 15 min before virus adsorption.
Synthesis of viral DNA. The induced RNA polymerase and acid deoxyribonuclease are late functions (6, 11) , i.e., dependent upon viral DNA synthesis. Streptovaricin inhibition of late enzyme induction could have been a result of inhibiting viral DNA synthesis. The following experiment indicates that streptovaricin can inhibit the onset of viral DNA synthesis if added early in the infection process.
Cells were infected with cowpox (10 pockforming unit/cell). The culture was divided, and streptovaricin (10 ,ug/ml) was added to infected cultures at the times indicated. Portions of infected cells (5 x 106 cells) were collected at intervals, and the rate of viral DNA synthesis was determined by pulse-labeling with tritiated thymidine (15-min pulse, 1 mCi of 3H-thymidine/ ml). Streptovaricin added at or before the time of viral adsorption markedly reduced the rate of viral DNA synthesis. Addition of streptovaricin at 1 hr postinfection, i.e., about the time that viral DNA synthesis commenced, was much less inhibitory (Fig. 5) . Inhibition of all early events was reversible, since removal of streptovaricin by suspension of cell in inhibitor-free medium permitted DNA synthesis to start.
Early messenger RNA transcription. ,ug/ml) for 1.5 hr, and then infected with cowpox at 10 pock-forming units/cell. After adsorption, the cultures were diluted to 5 x 10 cells/ml in growth medium containing cycloheximide (100 tAg/ml), and at intervals the rate of uridine incor-7 poration into viral mRNA was determined.
Evidence that incorporation of uridine in this system measures the rate of viral mRNA synthesis has been presented (2) . The effect of increasing doses of streptovaricin on RNA transcription by Ez l/cowpox cores in vivo is shown in Fig. 6 (Fig. 7) . Strepto-
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varicins A and C at the same concentration as used for the conplex were without effect on mRNA transcription by cowpox cores. Demonstration, by physicochemical techniques, of the streptovaricin inhibition of mRNA synthesis will be presented subsequently (manuscript in particles or interfered with synthesis of mRNA by active particles.
Cells were pretreated for 1.5 hr with cycloheximide as described above. Replicate cultures were infected with cowpox (10 pock-forming units/ml), and streptovaricin (10 ,ug/ml) was added to at 15 min before adsorption, 1 min before adsorption, and at 20 or 45 min postadsorption. The period of adsorption was exactly 10 min. In addition, one culture was infected at the same input multiplicity with cowpox that had been pretreated with streptovaricin as follows. Cowpox stock virus in 0.01 M Tris-hydrochloride, pH 7.8, was adjusted to a streptovaricin concentration of 10 ag/ml and allowed to stand at room temperature for 30 min. The virus concentration in the treated stock was such that the streptovaricin contributed to the culture during the period that the virus was adsorbing to the cells was only 0.1 ,g/ml. As a control, cells were infected with untreated cowpox, and streptovaricin was added 1 min before infection at a final concentration of 0.1 ,ug/ml.
Incorporation of uridine into viral mRNA was determined by pulse-labeling (Fig. 8) . It was found that streptovaricin (final concentration 10 ,ug/ml) could effectively reduce uridine incorporation even if added after viral mRNA synthesis had started. Streptovaricin did not inhibit adsorption of virus to cells (unpublished observations). Pretreatment of cowpox virus in vitro with streptovaricin at a concentration that effectively prevents cowpox mRNA synthesis in vivo did not prevent subsequent activation of the treated virus in vivo to a state capable of mRNA synthesis.
Effect of streptovaricin on in vitro mRNA synthesis by viral cores. Viral "cores" capable of mRNA synthesis in vitro can be obtained either by enzymatic or detergent treatment of virus (3, 4) or by allowing viral cores to accumulate in cycloheximide-treated cells (2) . Viral cores were prepared by detergent treatment (4) or by disrupting cells infected in the presence of cycloheximide (2) . In the latter case, only a crude cytoplasmic fraction was employed. These will be referred to as detergent cores or natural cores, respectively.
The effect of streptovaricin on mRNA synthesis in vitro by cores is given in Table 2 . Streptovaricin was added to the core preparations 10 RNA synthesis, as measured by uridine incorporation, was highly sensitive to streptovaricin complex. However, the inhibition of early viral mRNA synthesis is unlikely to be a secondary result of inhibiting cell RNA synthesis for the following reasons. (i) Conversion of virus to an active core is a constitutive process occurring very rapidly in vivo (3, 5) .
(ii) Pretreatment of cells with actinomycin D to reduce cell RNA synthesis by 99 % does not prevent activation and uncoating of virus (10) . (iii) High concentrations of streptovaricin C severely depressed host RNA synthesis but did not block early viral mRNA synthesis. (iv) Streptovaricin is effective even when added after mRNA synthesis has commenced (Fig. 8) . A pure streptovaricin fraction isolated from the complex markedly inhibits uridine incorporation into viral mRNA at doses that have little effect on host RNA synthesis. We do not think the difference between strains is absolute. Higher concentrations of streptovaricins will inhibit WR and rabbitpox virus.
There remains an apparent discrepancy between the effectiveness of streptovaricin in vivo and its lack of effect on core RNA synthesis in vitro. Among several possibilities we are investigating are that (i) the active streptovaricin component must undergo a conversion in vivo, or (ii) streptovaricin makes early viral mRNA highly unstable in vivo. Studies are being continued with the individual streptovaricins to compare activity with structure and to determine the mechanism of inhibition.
